Plain-English translation of NCT07630649 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
Adverum Biotechnologies, Inc.
Enrollment target
~15 participants
Started
June 2026
Primary completion
June 2031
Age range
50 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Adverum Study Contact
Adverum Biotechnologies, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.